Cargando…
Precision medicine: from pharmacogenomics to pharmacoproteomics
Disease progression and drug response may vary significantly from patient to patient. Fortunately, the rapid development of high-throughput ‘omics’ technologies has allowed for the identification of potential biomarkers that may aid in the understanding of the heterogeneities in disease development...
Autores principales: | Chambliss, Allison B., Chan, Daniel W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037608/ https://www.ncbi.nlm.nih.gov/pubmed/27708556 http://dx.doi.org/10.1186/s12014-016-9127-8 |
Ejemplares similares
-
Pharmacoproteomic characterisation of human colon and rectal cancer
por: Frejno, Martin, et al.
Publicado: (2017) -
Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery
por: Huttunen, Kristiina M., et al.
Publicado: (2022) -
Integrating Pharmacoproteomics into Early-Phase Clinical Development: State-of-the-Art, Challenges, and Recommendations
por: Nandal, Savita, et al.
Publicado: (2017) -
Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes
por: Calamia, Valentina, et al.
Publicado: (2010) -
A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine
por: Calamia, Valentina, et al.
Publicado: (2014)